4 Regulation of Biosimilars in Latin America

4

Regulation of
Biosimilars
in Latin America

AHF Convenes Latin American Experts On Biosimiliars To Review WHO Implementation
Guidelines in Region/Develop Recommendations for Harmonized Regulations

Recommendations for the Regulation of Biosimilars
and their Implementation in Latin America

The Americas Health Foundation (AHF) convened a panel of six Latin American experts on biosimilars in December 2013 to review the current use of these biopharmaceutical agents in Latin America. The Workgroup discussed current regulatory pathways and developed recommendations on how best to improve the process and achieve harmonization between countries in the Region. The article, 'Recommendations for the regulation of biosimilars and their implementation in Latin America', was published in the GaBI Journal in June 2014. Click here to read the article.

Click on the link to see a news clip, which is also available at the The Americas Health Foundation YouTube page.

PANELISTS INCLUDED